ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.95
0.15%
US Tech 100
20,608.62
-0.01%
S&P 500
6,041.01
-0.10%
US Dollar vs CAD
1.40662
0.15%
Bitcoin
95,211.08
-0.69%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) News

GSK

Gsk (GSK)

Gsk Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GSK
DateTimeSourceHeadlineSymbolCompany
12/02/20249:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
12/02/20249:00AMRNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
11/27/20243:23AMAlliance NewsAlliance NewsTOP NEWS: GSK hails EU Approval of Menveo vaccine in new formatLSE:GSKGsk Plc
11/27/20243:23AMAlliance NewsAlliance NewsTOP NEWS: GSK hails EU Approval of Menveo vaccine in new formatLSE:GSKGsk Plc
11/27/20241:00AMRNS Regulatory NewsGSK PLC GSK liquid meningitis vaccine authorised in EULSE:GSKGsk Plc
11/25/20242:54AMAlliance NewsAlliance NewsGSK's Blenrep combinations accepted for review by US FDALSE:GSKGsk Plc
11/25/20242:54AMAlliance NewsAlliance NewsGSK's Blenrep combinations accepted for review by US FDALSE:GSKGsk Plc
11/25/20241:00AMRNS Regulatory NewsGSK PLC Blenrep combinations accepted for US FDA reviewLSE:GSKGsk Plc
11/22/20242:40AMAlliance NewsAlliance NewsTOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59LSE:GSKGsk Plc
11/22/20242:40AMAlliance NewsAlliance NewsTOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59LSE:GSKGsk Plc
11/22/20241:00AMRNS Regulatory NewsGSK PLC Japan approves first RSV vaccine for adults 50-59LSE:GSKGsk Plc
11/19/20249:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/19/20243:24AMAlliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
11/19/20243:24AMAlliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
11/19/20241:00AMRNS Regulatory NewsGSK PLC GLISTEN Trial of Linerixibat Meets EndpointLSE:GSKGsk Plc
11/14/20242:54AMAlliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
11/14/20242:54AMAlliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
11/14/20241:00AMRNS Regulatory NewsGSK PLC GSK announces overall survival results for BlenrepLSE:GSKGsk Plc
11/13/20249:00AMRNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
11/12/20249:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/11/20249:01AMRNS Regulatory NewsGSK PLC GSK publishes provisional 2025 dividend datesLSE:GSKGsk Plc
11/04/202410:16AMAlliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
11/04/202410:16AMAlliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
11/01/202410:00AMRNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
10/30/20249:29AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
10/30/20244:28AMAlliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
10/30/20244:28AMAlliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
10/30/20242:00AMRNS Regulatory NewsGSK PLC 3rd Quarter ResultsLSE:GSKGsk Plc
10/29/20247:48AMAlliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
10/29/20247:48AMAlliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Your Recent History

USOTC
RDAR
Raadr (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
IFUS
Impact Fusion (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
COOP
Mr Cooper
USOTC
ASII
Accredited Solutions (PK)
USOTC
CBRF
CyberFuels (PK)
USOTC
ABQQ
AB (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
NBRI
North Bay Resources (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
AZRH
Azure (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved